You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 17, 22 SEPTEMBER 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL OBSERVATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Torsade de Pointes and Low-Dose Oral Haloperidol

Teresa Jackson; Leonard Ditmanson, MD; Brendan Phibbs, MD

Arch Intern Med. 1997;157(17):2013-2015.


Abstract

Haloperidol, used to treat patients with psychoses, is considered minimally cardiotoxic. Several cases of torsade de pointes have been reported in association with the use of oral haloperidol. In each of those cases, a prolonged QTC preceded the torsade de pointes episode and thus may be considered a predictor for ventricular arrhythmias in elderly women treated with haloperidol. However, the following case may demonstrate the inability to predict an episode of torsade de pointes with low-dose oral haloperidol use.

Arch Intern Med. 1997;157:2013-2015



Author Affiliations

From the College of Medicine, University of Arizona (Ms Jackson), and the Department of Clinical Medicine, Kino Community Hospital (Drs Ditmanson and Phibbs), Tucson, Ariz.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of concomitant amiodarone and haloperidol on Q-Tc interval prolongation
Bush et al.
Am J Health Syst Pharm 2008;65:2232-2236.
ABSTRACT | FULL TEXT  

Conventional and Atypical Antipsychotics and the Risk of Hospitalization for Ventricular Arrhythmias or Cardiac Arrest
Liperoti et al.
Arch Intern Med 2005;165:696-701.
ABSTRACT | FULL TEXT  

Safety of Patients Reason for FDA Black Box Warning on Droperidol * Response
Shafer et al.
Anesth. Analg. 2004;98:551-552.
FULL TEXT  

Antipsychotics and sudden death: is thioridazine the only bad actor?
RAY and MEADOR
Br. J. Psychiatry 2002;180:483-484.
FULL TEXT  

Electrophysiologic Characterization of the Antipsychotic Drug Sertindole in a Rabbit Heart Model of Torsade de Pointes: Low Torsadogenic Potential Despite QT Prolongation
Eckardt et al.
J. Pharmacol. Exp. Ther. 2002;300:64-71.
ABSTRACT | FULL TEXT  

Antipsychotics and the Risk of Sudden Cardiac Death
Ray et al.
Arch Gen Psychiatry 2001;58:1161-1167.
ABSTRACT | FULL TEXT  

Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes
Darpo
Eur Heart J Suppl 2001;3:K70-K80.
ABSTRACT  

Task Force on Sudden Cardiac Death of the European Society of Cardiology
Priori et al.
Eur Heart J 2001;22:1374-1450.
 

Acute Canine Model for Drug-Induced Torsades de Pointes in Drug Safety Evaluation--Influences of Anesthesia and Validation with Quinidine and Astemizole
Yamamoto et al.
Toxicol Sci 2001;60:165-176.
ABSTRACT | FULL TEXT  

Torsade or Not Torsade? That Is the Question
Verdino et al.
Arch Intern Med 1998;158:1578-1579.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.